McGill Center for Studies in Aging
Verdun, Quebec, Canada
Research institute in Montreal, Quebec
6825 Bd LaSalle, Verdun, QC H4H 1R3
About McGill Center for Studies in Aging
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Washington University School of Medicine
4
TauRx Therapeutics Ltd
2
Biogen
1
Cephalon
1
McGill University
1
National Institute on Aging (NIA)
1
Tharick Pascoal
1
Clinical Trials at McGill Center for Studies in Aging
During the past decade, McGill Center for Studies in Aging conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
2002-03-01
2005-08-01
Terminated
806
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
2013-05-01
2016-02-01
Completed
220
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
2012-12-01
2027-10-01
Recruiting
490
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
2014-08-01
2017-05-01
Terminated
913
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-08-13
2019-08-08
Terminated
1,653
Comprehensive Assessment of Neurodegeneration and Dementia
2016-06-01
2023-09-01
Recruiting
2,300
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
2012-12-01
2020-03-06
Completed
194
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "McGill Center for Studies in Aging" #1 sponsor was "Washington University School of Medicine" with 4 trials, followed by "TauRx Therapeutics Ltd" with 2 trials
sponsored, "Biogen" with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "McGill University"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McGill Center for Studies in Aging"
#1 collaborator was "National Institute on Aging (NIA)" with 5 trials as a collaborator, "Alzheimer's Association" with 4 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Hoffmann-La Roche" with 3 trials as a collaborator. Other collaborators include 19 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at McGill Center for Studies in Aging
According to Clinical.Site data, the most researched conditions in "McGill Center for Studies in Aging" are
"Dementia" (5 trials), "Alzheimers Disease" (4 trials), "Alzheimers Disease, Familial" (4 trials), "Alzheimer Disease" (2 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "McGill Center for Studies in Aging" in a lesser frequency.
Clinical Trials Intervention Types at McGill Center for Studies in Aging
Most popular intervention types in "McGill Center for Studies in Aging" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gantenerumab" (3 trials), "Matching Placebo (Gantenerumab)" (3 trials), "E2814" (2 trials), "Lecanemab" (2 trials) and "Matching Placebo (E2814)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at McGill Center for Studies in Aging
The vast majority of trials in "McGill Center for Studies in Aging" are
11 trials for "All" genders.
Clinical Trials Status at McGill Center for Studies in Aging
Currently, there are NaN active trials in "McGill Center for Studies in Aging".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in McGill Center for Studies in Aging,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in McGill Center for Studies in Aging, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".